European Factors to Watch-Shares seen steady, health sector in focus

lunes 12 de enero de 2015 02:34 GYT
 

LONDON, Jan 12 (Reuters) - European shares were seen opening steady on
Monday, with healthcare stocks likely to come into focus after Shire Plc 
 agreed to buy NPS Pharmaceuticals Inc for $5.2 billion.
    
    Financial spreadbetters expected Britain's FTSE 100 to open down by
10-14 points, or 0.2 percent lower. Germany's DAX was expected to open
up by 11.5-31.5 points, or 0.1-0.3 percent higher, while France's CAC 40 
was seen opening flat.
    
    Europe bourses in 2014: (link.reuters.com/pad95v)
    Asset performance in 2014: (link.reuters.com/rav46v)
------------------------------------------------------------------------------
  
 MARKET SNAPSHOT AT 0631 GMT                                 
                                            LAST    PCT CHG  NET CHG
 S&P 500                                2,044.81    -0.84 %   -17.33
 NIKKEI                                17,197.73     0.18 %    30.63
                                                                    
 EUR/USD                                  1.1865     0.22 %   0.0026
 USD/JPY                                  118.21    -0.24 %  -0.2900
 10-YR US TSY                              1.950         --    -0.02
 YLD                                                         
 10-YR BUND YLD                            0.485         --     0.00
 SPOT GOLD                             $1,229.31     0.54 %    $6.66
 US CRUDE                                 $47.56    -1.65 %    -0.80
 
  > GLOBAL MARKETS-DOLLAR SLIPS WITH YIELDS, OIL STILL SINKING 
  > US STOCKS-WALL ST RETREATS AFTER TWO-DAY ADVANCE; JOBS DATA MIXED  
  > TREASURIES-PRICES RISE AS WALL ST SLIDES, OIL DECLINES 
  > FOREX-WAGE FALL MAKES DOLLAR BULLS COOL HEELS, AUSSIE OUTPERFORMS 
  > PRECIOUS-GOLD CLIMBS TO ONE-MONTH HIGH ON WEAKER DOLLAR, OIL 
  > METALS-LONDON COPPER MIRED NEAR 4-1/2 YEAR LOWS ON GROWTH WORRIES 
  > OIL PRICES EXTEND FALLS; GOLDMAN SACHS SLASHES PRICE FORECASTS 
    
    COMPANY NEWS:
    
    SHIRE :
    Shire Plc  has agreed to buy NPS Pharmaceuticals Inc
 for $5.2 billion in its biggest acquisition yet, as the Dublin-based
drugmaker strengthens its position in the lucrative field of medicines for rare
diseases. 
    
    SANOFI :
    The European Medicines Agency has agreed to review an application by Sanofi
 and Regeneron for their cholesterol-lowering drug alirocumab,
the pharmaceutical groups said in a statement. 
    
    ROCHE :
    Swiss drug maker Roche Holding AG plans to acquire a majority stake
in U.S.-based molecular and genomic analysis firm Foundation Medicine Inc
 by buying a combination of outstanding and newly issued shares, the
companies said on Monday. 
    
    ROYAL BANK OF SCOTLAND :
    Royal Bank of Scotland Group Plc is preparing to withdraw from its
Asian corporate banking business and put most of it up for sale, according to a
report by Bloomberg citing a person with knowledge of the discussions.
 
    
    UBS :
    UBS Group AG, Switzerland's biggest bank, has lost two more
blue-chip corporate broking clients, the Financial Times reported, citing people
familiar with the situation. British-based defense contractor BAE Systems Plc
 and Smith & Nephew Plc, Europe's largest maker of artificial
joints, have both dropped UBS as their corporate broking adviser, the newspaper
said. (on.ft.com/1xSdTSR)
    
    VOLKSWAGEN :
    Germany's Volkswagen said on Sunday global December sales rose
2.7 percent to 881,000 vehicles as sales across VW's multi-brand group rose on
faster growth in China and Europe that outweighed falling sales in the United
States and Latin America. 

 (Reporting by Sudip Kar-Gupta; Editing by Atul Prakash)